ATLASPortfolio Building Block World Pharma And Biotech Index ETF (PBPH): outlook, holdings and fees
Portfolio Building Block World Pharma And Biotech Index ETF (PBPH) is an exchange-traded fund and is managed by Portfolio Building Block ETFs. The ten largest holdings are 64% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on PBPH
| Last price | $31.09 (-0.8%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 53% |
| Likely 1-month range (50%) | $30.06 – $32.40 |
| Normal 1-day range (±1σ) | ±1.3% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
PBPH fund facts
| Issuer | Portfolio Building Block ETFs |
|---|---|
| Theme | Biotech |
| Assets under management | $1.1B |
| Number of holdings | 49 |
| Inception | Nov 25, 2025 |
| Exchange | NASDAQ |
The fund uses a "passive management" approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund"s net assets in component securities that make up the index. The fund is non-diversified.
PBPH top holdings
| Holding | Sector | Weight |
|---|---|---|
| Eli Lilly and Company LLY | Healthcare | 16.26% |
| Johnson & Johnson JNJ | Healthcare | 9.53% |
| AbbVie Inc ABBV | Healthcare | 7.81% |
| Merck & Company Inc MRK | Healthcare | 5.47% |
| Roche Holding AG ROP | Healthcare | 4.81% |
| AstraZeneca PLC AZN | Healthcare | 4.71% |
| Amgen Inc AMGN | Healthcare | 4.20% |
| Novartis AG NOVN | Healthcare | 3.90% |
| Gilead Sciences Inc GILD | Healthcare | 4.07% |
| Pfizer Inc PFE | Healthcare | 3.53% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
PBPH sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 68.7%, Europe Developed 18.1%, United Kingdom 7.1%, Japan 3.7%, Australasia 1.4%.
PBPH returns and risk
| Year to date | +12.9% |
|---|---|
| Volatility (3 years) | 0.0% |
| Sharpe ratio (3 years) | 0.00 |
Past returns do not guarantee future results.
PBPH: frequently asked questions
What does PBPH invest in?
Portfolio Building Block World Pharma And Biotech Index ETF invests in a portfolio of securities. Its largest holdings are Eli Lilly and Company (16.3%), Johnson & Johnson (9.5%), AbbVie Inc (7.8%), Merck & Company Inc (5.5%), Roche Holding AG (4.8%).
Will PBPH go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 53%, with a likely range (50%) of $30.06 to $32.40 from $31.09 today. It is a probability, not a prediction.
Similar ETFs: Biotech
Educational information, not investment advice. Disclaimer